BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Foot Ulcer Market – Forecast to 2030,’ thoroughly examines the Foot Ulcer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Lipodystrophy Market – Forecast to 2030,’ thoroughly examines the Lipodystrophy industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Lewy Body Dementia Treatment Market – Forecast to 2030,’ thoroughly examines the Lewy Body Dementia Treatment industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Stress Urinary Incontinence Market – Forecast to 2030,’ thoroughly examines the Stress Urinary Incontinence industry to provide essential data & information for the targeted readers.

Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announced financial results for the second quarter of 2022.

MaxCyte, Inc. announced financial results for the second quarter and six months ended June 30, 2022.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, announced its second quarter 2022 financial results and provided a business update.

Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases, announced its financial results for the second quarter ended June 30, 2022, and recent corporate developments.

Dyadic International, Inc. announced its financial results for the second quarter of 2022, and highlighted recent company developments.

TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, reported financial results for the second quarter ended June 30, 2022.